4//SEC Filing
Edick Paul R 4
Accession 0001867096-21-000080
CIK 0001867096other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:25 PM ET
Size
9.1 KB
Accession
0001867096-21-000080
Insider Transaction Report
Form 4
Edick Paul R
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2021-11-15$2.28/sh+20,000$45,664→ 33,430 total(indirect: By Trust)
Holdings
- 808,064
Common Stock
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.275 to $2.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001531178
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 4:25 PM ET
- Size
- 9.1 KB